Interrelations Between Spontaneous Otoacoustic Emissions and Transient Evoked Emissions
NCT ID: NCT01325272
Last Updated: 2011-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
2009-03-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Neurologic Development of Temporal Voice Area (TVA) in Deaf Infant
NCT02379611
False Positive Results in Newborn Hearing Screening
NCT00753194
Body Movements Analysis During Sleep in Very Premature Infants
NCT03432182
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
NCT01291797
Results of a Program of Newborn Hearing Screening (NHS) in Cuiaba-Brazil
NCT01113450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preterm newborn
No interventions assigned to this group
term newborn
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have presence of transient otoacoustic emission
Exclusion Criteria
4 Days
5 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UPECLIN HC FM Botucatu Unesp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Faculdade de Medicina de Botucatu
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniela Polo Camargo da Silva, Mestre
Role: PRINCIPAL_INVESTIGATOR
Faculdade de Medicina de Botucatu
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculdade de Medicina de Botucatu
Botucatu, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
upeclin/HC/FMB-Unesp-53
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.